Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
121 - 130 of 155 results
- Panagiotis Stamatiadis (Member)
- Amanda Tanamachi (Member)
- Kris Thielemans (Member)
- Jonathan Tresignie (Member)
- Maria Tryfonos (Member)
- Chenggong Tu (Member)
- Elsy Vaeremans (Member)
- Hilde Van De Velde (Member)
- Guy Van Der Sande (Member)
- Lien Ann Van Hemelrijck (Member)
Projects
121 - 130 of 141
- De-convolution of tumour biology in the post-genomic era: focus on pancreatic cancerFrom1 Oct 2016 → 1 Oct 2021Funding: FWO Odysseus
- Targeting residual, dormant cancer cells in myeloma: a new approachFrom1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships
- IMAGica: an Integrative personalised Medical Approach for Genetic diseases, Inherited Cardiac Arrhythmias as a modelFrom1 Jul 2016 → 30 Jun 2023Funding: University - Project driven research
- advanced Metabolomics Platform consisting of two complementary LC-MS/MS analyzersFrom1 May 2016 → 30 Apr 2020Funding: Hercules - Small and Medium size research infrastructure
- SEGa - The Science and Ethics of stem cell-derived GametesFrom1 Feb 2016 → 31 Jan 2020Funding: IWT / VLAIO - excluding impulse programmes
- GENEFIX: Development of muscle-targeted gene therapy for hemophilia B using longer-acting clotting factor IXFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- FWO-SB-beurs: Development of an mRNA-based vaccine to treat HPV-positive oropharyngeal squamous cell carcinoma: immunogenicity, therapeutic efficacy and safetyFrom1 Jan 2016 → 31 Dec 2017Funding: FWO fellowships
- A study to target tumor-associated macrophages in multiple myeloma.From1 Jan 2016 → 31 Dec 2016Funding: FWO research grant KAN
- Advanced T-cell Therapy for Augmented Cancer Killing ("ATTACK"): next-generation T-cell immunotherapy directed against lymphoid malignanciesFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- FWO-SB-beurs: Innovation through Combination: Identification of a novel combination therapy for improved treatment of EGFRFrom1 Jan 2016 → 31 Dec 2019Funding: FWO fellowships
Publications
1 - 10 of 1112
- PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF
Authors: Christos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, Leyun Pan, Caixia Cheng, Klaus Kopka, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss
Pages: 1343-1353 - Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6
Authors: Mathias Witzens-Harig, Dirk Hose, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Ludmila Umansky, Anja Seckinger, Heinke Conrad, Bettina Brackertz, Thierry Rème, et al.
Pages: 4493-4503 - Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone
Authors: Katja C Weisel, Christof Scheid, Manola Zago, Britta Besemer, Elias K Mai, Mathias Haenel, Jan Duerig, Markus Munder, Hans-Walter Lindemann, Anja Seckinger, et al.
- DNA repair pathways in human multiple myeloma
Authors: Claire Gourzones-Dmitriev, Alboukadel Kassambara, Surinder S Sahota, Thierry Rème, Jérôme Moreaux, Pascal Bourquard, Dirk Hose, Philippe Pasero, Angelos Constantinou, Bernard Klein
Pages: 2760-2773 - Daratumumab for systemic AL amyloidosis
Authors: Christoph R Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, et al.
Pages: 1517-1530 - Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma
Authors: Isabelle Herth, Mathias Witzens-Harig, Philipp Beckhove, Dirk Hose, Tobias Meissner, Brigitte Neuber, Melanie Engelhardt, Jürgen Haas, Kai Neben, Anthony D Ho, et al.
Pages: 231-240 - The histone deacetylase SIRT2 stabilizes Myc oncoproteins
Authors: P Y Liu, N Xu, A Malyukova, Christopher J Scarlett, Y T Sun, X D Zhang, D Ling, S-P Su, Claudia Benitez-Nelson, David K Chang, et al.
Pages: 503-514 - Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
Authors: Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlinde Egerer, Hans J Salwender, Igor W Blau, Katja Weisel, et al.
Pages: e116-e119 - Hitting the target without pulling the trigger.
Authors: Thierry VandenDriessche, Marinee K Chuah
Pages: 4-6 - Combinatorial strategies for the induction of immunogenic cell death.
Authors: L Bezu, LC Gomes-de-Silva, Heleen Dewitte, Karine Breckpot, J Fucikova, Radek Spisek, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer